Design
Review
Authors
Loading...
Supports exploration of vasopeptidase inhibitors; leaves open efficacy and safety in prospective trials.
Vasopeptidase inhibitors represent a promising therapeutic approach for hypertension, atherosclerosis, and heart failure by simultaneously targeting the renin-angiotensin and natriuretic peptide systems.
Corti et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: